FEDERATED HERMES, INC. - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 68 filers reported holding OVID THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$6,000
+50.0%
1,887
+53.3%
0.00%
Q3 2021$4,000
+300.0%
1,231
+392.4%
0.00%
Q2 2021$1,0000.0%250
-48.2%
0.00%
Q4 2020$1,000
-92.3%
483
-78.6%
0.00%
Q3 2020$13,000
+550.0%
2,258
+921.7%
0.00%
Q2 2020$2,000
+100.0%
221
-0.5%
0.00%
Q1 2020$1,0000.0%222
-30.6%
0.00%
Q4 2019$1,0003200.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
AWH Capital, L.P. 230,000$407,0000.69%
BVF INC/IL 3,293,000$5,829,0000.65%
COWEN INC. 1,101,414$1,950,0000.21%
ARMISTICE CAPITAL, LLC 1,780,000$3,151,0000.17%
Granite Point Capital Management, L.P. 417,857$740,0000.07%
Redmile Group, LLC 737,550$1,305,0000.04%
Tekla Capital Management LLC 496,977$880,0000.04%
Fairpointe Capital LLC 101,000$179,0000.01%
Alyeska Investment Group, L.P. 225,000$398,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,440$149,0000.00%
View complete list of OVID THERAPEUTICS INC shareholders